Table 1.
General characteristics of the study population of hypertensive outpatients treated with monotherapies
| Parameters | Overall sample | Age 18–65 years (%) | Age > 65 years (%) | P value |
|---|---|---|---|---|
| Outpatients (%) | 1575 (100.0) | 988 (62.7) | 587 (37.3) | – |
| Age (years) | 59.5 ± 13.6 | 51.2 ± 9.3 | 73.5 ± 6.0 | < 0.001 |
| BMI (kg/m2) | 26.6 ± 4.4 | 26.9 ± 4.7 | 26.0 ± 3.8 | 0.004 |
| Smoke (%) | 157 (17.5) | 120 (20.9) | 37 (11.4) | < 0.001 |
| Obesity (%) | 935 (59.4) | 612 (61.9) | 323 (55.0) | 0.007 |
| Dyslipidaemia (%) | 489 (31.0) | 246 (24.9) | 243 (41.4) | < 0.001 |
| Diabetes (%) | 142 (9.0) | 72 (7.3) | 70 (11.9) | 0.002 |
| CAD (%) | 27 (1.7) | 6 (0.6) | 21 (3.6) | < 0.001 |
| TIA/stroke (%) | 69 (4.4) | 28 (2.8) | 41 (7.0) | < 0.001 |
| Glucose (mg/dl) | 96.7 ± 23.0 | 96.7 ± 25.1 | 96.9 ± 16.7 | 0.936 |
| TOT-C (mg/dl) | 200.1 ± 37.4 | 202.2 ± 37.6 | 194.7 ± 36.7 | 0.080 |
| HDL-C (mg/dl) | 52.7 ± 13.9 | 52.4 ± 13.8 | 53.5 ± 14.3 | 0.524 |
| LDL-C (mg/dl) | 124.4 ± 35.7 | 127.2 ± 36.2 | 116.4 ± 33.3 | 0.013 |
| TG (mg/dl) | 117.0 ± 61.2 | 117.7 ± 65.1 | 115.3 ± 49.8 | 0.739 |
| Creatinine (mg/dl) | 0.96 ± 0.6 | 0.96 ± 0.7 | 0.95 ± 0.3 | 0.931 |
| Uric acid (mg/dl) | 5.6 ± 1.7 | 5.5 ± 1.6 | 6.1 ± 1.8 | 0.321 |
BMI body mass index, CAD coronary artery disease, TIA transient ischaemic attack, TOT-C total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, TG triglycerides, BUN blood urea nitrogen
*Risk scores were calculated only in those patients aged between 40 and 65 years